bibliographicCitation |
Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, Gonzalez-Santamaria J, Gonzalez D, Rodriguez MS, Rivas C. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. Journal of General Virology. 2010 Sep 29;92(1):188–94. doi: 10.1099/vir.0.024984-0. |